AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9014544
Drug: Target-controlled infusion
RxNorm normalized name: Diphtheria toxin-il-3 fusion protein targeting IL-3 receptor
DrugBank: Tagraxofusp (DB14731)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Target-controlled infusion of propofol (4 micrograms.ml‐1 target blood concentration, increased by 2 micrograms.ml‐1 after 3 min of consciousness not lost)
Trial: 9014544
Drug: Manual infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Manual infusion of propofol (both rates)
Trial: 7884236
Drug: Intraoperative pelvic
RxNorm normalized name: Sus scrofa renal pelvis preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative pelvic hyperthermochemotherapy (IOPHC) with 40 micrograms/ml mitomycin C at 45 degrees C for 90 min
Trial: 7884236
Drug: IOPHC treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IOPHC treatment
Trial: 2448428
Drug: Postoperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative chemotherapy with doxorubicin (DOX) and cisplatin (CPDD) for poor responders
Trial: 22615342
Drug: Mediterranean diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mediterranean diet with low cholesterol intake (<300 mg/d)
Trial: 18227981
Drug: Intravenous analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous analgesia with 1.5 microg/ml/kg/h fentanyl followed by 1.0 microg/ml/kg/h fentanyl
Trial: 10551568
Drug: 1.8 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.8 g/kg perflubron emulsion with colloid (total = 450 ml) at FIO2 = 1.0
Trial: 10551568
Drug: 0.9 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9 g/kg perflubron emulsion with colloid (total = 450 ml) at FIO2 = 1.0
Trial: 8903371
Drug: 3 MU
RxNorm normalized name: Orasep Reformulated Dec 2013 Mucosal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 MU of interferon alfa‐2b thrice weekly for 12 weeks
Trial: 8903371
Drug: 5 MU
RxNorm normalized name: MULTISTIX 5 MULTIPLE TEST STRIP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 MU of interferon alfa‐2b thrice weekly for 12 weeks
Trial: 8903371
Drug: 10 MU
RxNorm normalized name: saliva substitute comb no.10 MUCOUS MEM POWDER IN PACKET (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 MU of interferon alfa‐2b thrice weekly for 12 weeks
Trial: 8903371
Drug: Continued therapy
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continued therapy at 3 MU for an additional 12 weeks for nonresponders
Trial: 8903371
Drug: Escalated dose
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escalated dose from 3 or 5 MU to 10 MU for nonresponders
Trial: 1437036
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution rinse
Trial: 2681593
Drug: Other drugs
RxNorm normalized name: Other drugs for bile therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other drugs modifying myogenic tone
Trial: 18321517
Drug: Naproxen suppository
RxNorm normalized name: naproxen Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen suppository
Trial: 12661806
Drug: Beclomethasone diproprionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone diproprionate (50 microg/puff) with Salbutamol (100 microg/puff) by metered dose inhaler with or without spacer
Trial: 9366582
Drug: R‐568 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R‐568 80 mg
Trial: 9366582
Drug: R‐568 160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R‐568 160 mg
Trial: 8004841
Drug: Bisoprolol 10
RxNorm normalized name: bisoprolol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol 10 mg
Trial: 17714557
Drug: Preoperative proton
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative proton pump inhibitor‐based triple therapy (rabeprazole 10 mg, clarithromycin 500 mg, amoxicillin 1,000 mg, twice daily for 7 days)
Trial: 17714557
Drug: Postoperative proton
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative proton pump inhibitor‐based triple therapy (rabeprazole 10 mg, clarithromycin 500 mg, amoxicillin 1,000 mg, twice daily for 7 days)
Trial: 17714557
Drug: Postoperative proton
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative proton pump inhibitor‐based triple therapy (Billroth I)
Trial: 17714557
Drug: Postoperative proton
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative proton pump inhibitor‐based triple therapy (Billroth II)
Trial: 10744143
Drug: gemfibrozil treatment
RxNorm normalized name: Gemfibrozil
DrugBank: Gemfibrozil (DB01241)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: gemfibrozil treatment
Trial: 2009056
Drug: Chemoendocrine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoendocrine therapy (specific combinations not detailed)
Trial: 2009056
Drug: No systemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No systemic therapy (control group)
Trial: 7272159
Drug: Twice-daily flurbiprofen
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily flurbiprofen
Trial: 30029461
Drug: 8 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 g/day polydextrose
Trial: 30029461
Drug: 12 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 g/day polydextrose
Trial: 31732715
Drug: Ketamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine infusion (0.5 mg/kg) over 40 minutes
Trial: 11182190
Drug: Trimetazidine (TMZ)
RxNorm normalized name: trimetazidine
DrugBank: Trimetazidine (DB09069)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimetazidine (TMZ) 20 mg tid plus conventional therapy (thrombolytic therapy, aspirin, beta-blocker, heparin, intravenous nitroglycerin)
Trial: 11182190
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (thrombolytic therapy, aspirin, beta-blocker, heparin, intravenous nitroglycerin)
Trial: 24530385
Drug: Ketoprofen gel
RxNorm normalized name: Ketoprofen
DrugBank: Ketoprofen (DB01009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoprofen gel
Trial: 24943961
Drug: Weekly azithromycin
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Weekly azithromycin for 3 weeks
Trial: 22619063
Drug: Week 12
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Week 12 HCV RNA cutoff of ≥ 100 IU/mL stopping rule
Trial: 22619063
Drug: Week 12
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Week 12 HCV RNA levels between 9.3 IU/mL and 25 IU/mL
Trial: 22619063
Drug: Week 12
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Week 12 HCV RNA level of 148 IU/mL
Trial: 22619063
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of stopping rules (HCV RNA level ≥ 100 IU/mL at week 12 and detectable HCV RNA at week 24)
Trial: 16970099
Drug: Shufei Granule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shufei Granule (SG) 10 g 3 times a day orally, in addition to control treatment.
Trial: 16970099
Drug: Fleroxacin 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fleroxacin 0.2 g twice per day by intravenous dripping and diprophylline 0.2 g 3 times per day orally (Control group).
Trial: 12913678
Drug: Anti-oxidant and
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-oxidant and micronutrient therapy
Trial: 8694015
Drug: Fungal oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fungal oil (3.6 g AA, 2.9 g DHA)
Trial: 8694015
Drug: Fungal oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fungal oil (0 g AA, 0 g DHA)
Trial: 8694015
Drug: Fungal oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fungal oil (0.8 g AA, 0.6 g DHA)
Trial: 30384375
Drug: Palosuran 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palosuran 500 mg b.i.d.
Trial: 27260129
Drug: Doxazosin 4
RxNorm normalized name: doxazosin 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin 4 mg and tolterodine ER 4 mg per day
Trial: 27260129
Drug: Tamsulosin 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.2 mg and tolterodine ER 4 mg per day
Trial: 17654694
Drug: Levodopa 100
RxNorm normalized name: levodopa 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levodopa 100 mg t.i.d. with sarizotan 5 mg b.i.d.
Trial: 17654694
Drug: Levodopa 100
RxNorm normalized name: levodopa 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levodopa 100 mg t.i.d. without sarizotan
Trial: 8087189
Drug: Sodium cromoglycate
RxNorm normalized name: Sodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium cromoglycate (SCG) 10 mg
Trial: 26821045
Drug: Oral exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral exposure duration of 8 min
Trial: 26821045
Drug: Oral exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral exposure duration of 1 min
Trial: 17118686
Drug: Budesonide/formoterol pMDI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol pMDI 160/4.5 microg, two inhalations twice daily
Trial: 17118686
Drug: Budesonide/formoterol DPI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol DPI 160/4.5 microg, two inhalations twice daily
Trial: 16544967
Drug: Minoxidil (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minoxidil (5 mg)
Trial: 1363892
Drug: New drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New drugs (Navelbine, taxol, campthotecine) for NSCLC chemotherapy
Trial: 1363892
Drug: Dose intensity
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dose intensity improvement with growth factors for SCLC
Trial: 1363892
Drug: Fractionation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractionation of therapy for SCLC
Trial: 11863478
Drug: Transferrin receptor-ferritin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transferrin receptor-ferritin index (TR-F index)
Trial: 2268867
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg of cefuroxime axetil orally (250 mg q12h)
Trial: 2268867
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg of cefuroxime axetil orally (500 mg q12h)
Trial: 27527354
Drug: DPBN-16 Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DPBN-16 Gy (dose range between 14 and 18 Gy)
Trial: 25591433
Drug: Ringer lactate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ringer lactate solution (RL) group
Trial: 23673291
Drug: Oxycodone hydrochloride
RxNorm normalized name: Oxycodone Hydrochloride
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxycodone hydrochloride (HCl) extended release (ER) tablets (test formulation)
Trial: 19514189
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine group (Nimesulide tablets)
Trial: 19514189
Drug: Point-injection group
RxNorm normalized name: meningococcal group B vaccine Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Point-injection group (Anisodamine injected)
Trial: 17339748
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human growth hormone (rhGH) 0.33 mg/day
Trial: 8240477
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream over the proposed epidural site for a minimum period of 5 min (mean 9.1 min)
Trial: 8240477
Drug: Skin bleb
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skin bleb and subcutaneous injection of lignocaine 2% (1 ml)
Trial: 2826064
Drug: Oxprenolol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxprenolol (80 mg orally)
Trial: 20595155
Drug: Ciclesonide (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciclesonide (160 μg s.i.d.)
Trial: 18291270
Drug: Two-visit root
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-visit root canal therapy with calcium hydroxide/chlorhexidine paste dressing
Trial: 16603430
Drug: Chinese herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbal preparation
Trial: 29284438
Drug: IMPaCT Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IMPaCT Therapy
Trial: 29284438
Drug: IMPaCT Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IMPaCT Therapy (>180 min)
Trial: 26268913
Drug: Cranberry (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranberry (500 mg daily for 6 months)
Trial: 23384111
Drug: Silicone gel
RxNorm normalized name: SILTREX Silicone Gel-Pad
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silicone gel applied to half of the chest scar for three months
Trial: 18327093
Drug: Manidipine 10
RxNorm normalized name: manidipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manidipine 10 mg and Delapril 30 mg
Trial: 8792950
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg and Hydrochlorothiazide 12.5 mg
Trial: 6754210
Drug: Multiple-dose Methyldopa
RxNorm normalized name: Methyldopa
DrugBank: Methyldopa (DB00968)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multiple-dose Methyldopa
Trial: 6754210
Drug: Multiple-dose Propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-dose Propranolol
Trial: 11907636
Drug: Amiodarone (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone (600 mg/d)
Trial: 11907636
Drug: Amiodarone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone (200 mg/d)
Trial: 9270900
Drug: Quetiapine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine (300 mg daily)
Trial: 9270900
Drug: Haloperidol (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (12 mg daily)
Trial: 9270900
Drug: Quetiapine (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine (all doses)
Trial: 9574474
Drug: Spa therapy
RxNorm normalized name: Broda Acne Spa
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spa therapy (Group 2, n = 74)
Trial: 3342283
Drug: Sustained-release tablets
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release tablets (T)
Trial: 21999623
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (10 mg/kg bolus prior to surgery)
Trial: 21999623
Drug: Fibrin spray
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrin spray (10 mL during surgery)
Trial: 21999623
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (neither treatment)
Trial: 6102677
Drug: Intraventricular gentamicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraventricular gentamicin plus systemic antimicrobial agents
Trial: 31067131
Drug: Handgrip isometric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Handgrip isometric training five times weekly
Trial: 27564409
Drug: Lesinurad 200
RxNorm normalized name: lesinurad 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lesinurad 200 mg added to allopurinol
Trial: 27564409
Drug: Lesinurad 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lesinurad 400 mg added to allopurinol
Trial: 27564409
Drug: Lesinurad 200
RxNorm normalized name: lesinurad 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lesinurad 200 mg and 400 mg added to allopurinol
Trial: 25829346
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (bevacizumab plus dexamethasone delivery system)
Trial: 23891461
Drug: Buprenorphine therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine therapy with escitalopram treatment for depressive symptoms
Trial: 17074798
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg voriconazole twice daily (BID) (400-mg BID loading doses on the first day), n = 16
Trial: 17074798
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg voriconazole twice daily (BID) with methadone
Trial: 16652380
Drug: 8‐week program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8‐week program of clinic‐based or self‐administered behavioral training
Trial: 10418181
Drug: Prefilled, disposable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prefilled, disposable insulin pen injector (Novolet)
Trial: 1691403
Drug: Quinapril (10-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril (10-40 mg/day, up to 80 mg/day)
Trial: 2650581
Drug: Quinapril (once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril (once daily)
Trial: 6271384
Drug: Concurrent chemotherapy‐irradiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemotherapy‐irradiation (CT‐RT)
Trial: 6271384
Drug: Three‐week course
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three‐week course of concurrent CT‐RT
Trial: 10922131
Drug: Concurrent therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent therapy
Trial: 6271384
Drug: Sequential CT‐RT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential CT‐RT
Trial: 31655841
Drug: Laser therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser therapy (K Laser Cube 3)
Trial: 21563042
Drug: Diclofenac epolamine
RxNorm normalized name: Diclofenac Epolamine
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac epolamine topical patch 1.3%
Trial: 18474882
Drug: Decreased antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Decreased antibiotic prescribing
Trial: 18474882
Drug: Knowledge, attitudes,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Knowledge, attitudes, or behaviors favoring judicious antibiotic use
Trial: 18474882
Drug: Concern about
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concern about antibiotic resistance
Trial: 8804327
Drug: Orally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally administered iron for 6 months
Trial: 6229429
Drug: Isotretinoin 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotretinoin 1.0 mg/kg
Trial: 6229429
Drug: Isotretinoin 0.5
RxNorm normalized name: isotretinoin 0.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotretinoin 0.5 mg/kg
Trial: 29288190
Drug: Organ-saving treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Organ-saving treatment using long-course concurrent chemoradiation
Trial: 19756664
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of etanercept and methotrexate (MTX)
Trial: 15449975
Drug: Perindopril 4
RxNorm normalized name: perindopril 4 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 4 mg/day for 6 weeks, then either maintained or increased to 8 mg/day based on BP response.
Trial: 15449975
Drug: Perindopril 8
RxNorm normalized name: perindopril 8 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 8 mg/day for 6 weeks (group II).
Trial: 15449975
Drug: Perindopril monotherapy.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril monotherapy.
Trial: 15449975
Drug: Perindopril 8
RxNorm normalized name: perindopril 8 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 8 mg/day for group II patients.
Trial: 15449975
Drug: Perindopril monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril monotherapy in hypertensive diabetic patients.
Trial: 15449975
Drug: Perindopril treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril treatment in very elderly patients (>75 years).
Trial: 15449975
Drug: Perindopril treatment.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril treatment.
Trial: 9331117
Drug: Paclitaxel 225
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 225 mg/m2 plus carboplatin (AUC 6)
Trial: 9164208
Drug: Paclitaxel 200
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 200 mg/m2